D-luciferin

D-luciferin is a small-molecule substrate that produces visible light in bioluminescent organisms and is widely used to monitor biological activity in laboratory research. In the presence of luciferase, ATP, oxygen, and magnesium ions, D-luciferin is enzymatically oxidized to oxyluciferin, releasing energy as photons. This light-producing reaction supports sensitive luciferase reporter assays, allowing researchers to measure gene expression, cellular processes, and enzyme activity. In biology, D-luciferin is also administered to cells or model organisms for bioluminescence imaging, where emitted light can reveal cell viability, track disease progression, or evaluate therapeutic responses over time.

D-luciferin - Related Videos

Research

JoVE Journal - Immunology and Infection

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

0 Views •

Cited by 14 •

2017

The method described here allows for the visualization of IL-8 promoter-dependent inflammation activation in the lungs of mice through non-invasive bioluminescence imaging (BLI). The same animal can be subjected to BLI multiple times for up to two months from the time of delivery of the luciferase reporter construct.

Bioluminescence Imaging to Assess Tumor Growth in an Organotypic Mouse Brain Slice

0 Views •

2025

Source: Ciraku, L., et. al. An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth. J. Vis. Exp. (2021).This video demonstrates the imaging of luciferase-expressing tumor cells in an organotypic mouse brain slice. Luciferin is added to the medium, and the plate is placed inside the chamber of the in vivo imaging system. Parameters for image capture are adjusted, and the tumor's shape and size are defined. The bioluminescent signals emitted by the tumor...

An In Vitro Assay to Evaluate the Anti-Tumor Activity of Tumor-Specific CAR T Cells

0 Views •

2025

This video demonstrates an in vitro assay to validate chimeric antigen receptor (CAR) T cell activity. B-cell lymphoma cells expressing CD19 antigen and cytoplasmic luciferase are co-cultured with CD19-specific CAR T cells. CAR binding to CD19 on a tumor induces the CAR T cells to release cytokines and toxins that cause tumor cell cytotoxicity. The CAR T cell activity is evaluated by quantifying the released cytokine and decreased luciferase-mediated bioluminescence in the tumor cells.

In Vivo Bioluminescence Imaging of Human Neural Progenitor Cells in a Mouse Brain

0 Views •

2025

Source: Weber, R. Z., et al., Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain. J. Vis. Exp. (2022)This video demonstrates the method for in vivo bioluminescence imaging of genetically modified human neural progenitor cells injected in a mouse brain. The process involves luciferin injection, imaging preparation, and detection of bioluminescent signals from the transplanted cells at the injection site.

Bioluminescence Imaging of Neuroinflammation in a Transgenic Mouse

0 Views •

2025

Source: Breid, S., et. al. Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils. J. Vis. Exp. (2017)This video demonstrates the bioluminescence imaging of neuroinflammation in transgenic mice, showcasing luciferase-luciferin reactions in activated astrocytes. The protocol enables non-invasive quantification of astrocytic activation, aiding studies on CNS inflammation and therapeutic efficacy.

View All Results

FAQs

Related Topics